Evaluation of locally recurrent pelvic malignancy: Performance of T2- and diffusion-weighted MRI with image fusion

Akihiro Nishie, Alan H. Stolpen, Masao Obuchi, David M. Kuehn, Aaron Dagit, Kelli Andresen

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Purpose: To evaluate the performance of T2- and diffusion-weighted magnetic resonance imaging (MRI) with image fusion for detection of locally recurrent pelvic malignancy. Materials and Methods: The study group consisted of 28 patients (27 female, 1 male) who underwent pelvic MRI at 1.5 T after treatment of pelvic malignancy. MR images were reviewed independently by three blinded readers. The performance of the four sequences for detecting local recurrence was evaluated using receiver operating characteristic analysis: T2-weighted fast spin-echo (FSE), diffusion-weighted echo-planar imaging (DWI), dynamic contrast-enhanced (DCE) fat-suppressed T1-weighted spoiled gradient echo (SPGR), and T2-DWI with image fusion, the latter created using OsiriX Medical Imaging Software. Results: Local recurrence was confirmed at biopsy in 16 patients. Twelve patients showed no evidence of recurrence on two consecutive MRI studies. The Az value for T2-DWI with image fusion (0.949) was statistically greater than that for T2-weighted FSE (0.849) (P < 0.05). The sensitivity and specificity was 87.5% and 47.2%, respectively, for T2-weighted FSE. 100.0% and 50.0% for DWI, 95.8% and 58.3% for DCE fat-suppressed T1-weighted SPGR, and 93.8% and 72.2% for T2-DWI with image fusion. Conclusion: For depicting locally recurrent pelvic malignancy, T2-DWI with image fusion outperforms standard T2-weighted FSE and DWI and is comparable to DCE fat-suppressed T1-weighted SPGR.

Original languageEnglish
Pages (from-to)705-713
Number of pages9
JournalJournal of Magnetic Resonance Imaging
Volume28
Issue number3
DOIs
Publication statusPublished - Sep 1 2008

Fingerprint

Diffusion Magnetic Resonance Imaging
Fats
Recurrence
Magnetic Resonance Imaging
Echo-Planar Imaging
Neoplasms
Diagnostic Imaging
ROC Curve
Software
Biopsy
Sensitivity and Specificity
Therapeutics

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Cite this

Evaluation of locally recurrent pelvic malignancy : Performance of T2- and diffusion-weighted MRI with image fusion. / Nishie, Akihiro; Stolpen, Alan H.; Obuchi, Masao; Kuehn, David M.; Dagit, Aaron; Andresen, Kelli.

In: Journal of Magnetic Resonance Imaging, Vol. 28, No. 3, 01.09.2008, p. 705-713.

Research output: Contribution to journalArticle

Nishie, Akihiro ; Stolpen, Alan H. ; Obuchi, Masao ; Kuehn, David M. ; Dagit, Aaron ; Andresen, Kelli. / Evaluation of locally recurrent pelvic malignancy : Performance of T2- and diffusion-weighted MRI with image fusion. In: Journal of Magnetic Resonance Imaging. 2008 ; Vol. 28, No. 3. pp. 705-713.
@article{4593a2b4c0fd42299fa1f7b00a663ae4,
title = "Evaluation of locally recurrent pelvic malignancy: Performance of T2- and diffusion-weighted MRI with image fusion",
abstract = "Purpose: To evaluate the performance of T2- and diffusion-weighted magnetic resonance imaging (MRI) with image fusion for detection of locally recurrent pelvic malignancy. Materials and Methods: The study group consisted of 28 patients (27 female, 1 male) who underwent pelvic MRI at 1.5 T after treatment of pelvic malignancy. MR images were reviewed independently by three blinded readers. The performance of the four sequences for detecting local recurrence was evaluated using receiver operating characteristic analysis: T2-weighted fast spin-echo (FSE), diffusion-weighted echo-planar imaging (DWI), dynamic contrast-enhanced (DCE) fat-suppressed T1-weighted spoiled gradient echo (SPGR), and T2-DWI with image fusion, the latter created using OsiriX Medical Imaging Software. Results: Local recurrence was confirmed at biopsy in 16 patients. Twelve patients showed no evidence of recurrence on two consecutive MRI studies. The Az value for T2-DWI with image fusion (0.949) was statistically greater than that for T2-weighted FSE (0.849) (P < 0.05). The sensitivity and specificity was 87.5{\%} and 47.2{\%}, respectively, for T2-weighted FSE. 100.0{\%} and 50.0{\%} for DWI, 95.8{\%} and 58.3{\%} for DCE fat-suppressed T1-weighted SPGR, and 93.8{\%} and 72.2{\%} for T2-DWI with image fusion. Conclusion: For depicting locally recurrent pelvic malignancy, T2-DWI with image fusion outperforms standard T2-weighted FSE and DWI and is comparable to DCE fat-suppressed T1-weighted SPGR.",
author = "Akihiro Nishie and Stolpen, {Alan H.} and Masao Obuchi and Kuehn, {David M.} and Aaron Dagit and Kelli Andresen",
year = "2008",
month = "9",
day = "1",
doi = "10.1002/jmri.21486",
language = "English",
volume = "28",
pages = "705--713",
journal = "Journal of Magnetic Resonance Imaging",
issn = "1053-1807",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Evaluation of locally recurrent pelvic malignancy

T2 - Performance of T2- and diffusion-weighted MRI with image fusion

AU - Nishie, Akihiro

AU - Stolpen, Alan H.

AU - Obuchi, Masao

AU - Kuehn, David M.

AU - Dagit, Aaron

AU - Andresen, Kelli

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Purpose: To evaluate the performance of T2- and diffusion-weighted magnetic resonance imaging (MRI) with image fusion for detection of locally recurrent pelvic malignancy. Materials and Methods: The study group consisted of 28 patients (27 female, 1 male) who underwent pelvic MRI at 1.5 T after treatment of pelvic malignancy. MR images were reviewed independently by three blinded readers. The performance of the four sequences for detecting local recurrence was evaluated using receiver operating characteristic analysis: T2-weighted fast spin-echo (FSE), diffusion-weighted echo-planar imaging (DWI), dynamic contrast-enhanced (DCE) fat-suppressed T1-weighted spoiled gradient echo (SPGR), and T2-DWI with image fusion, the latter created using OsiriX Medical Imaging Software. Results: Local recurrence was confirmed at biopsy in 16 patients. Twelve patients showed no evidence of recurrence on two consecutive MRI studies. The Az value for T2-DWI with image fusion (0.949) was statistically greater than that for T2-weighted FSE (0.849) (P < 0.05). The sensitivity and specificity was 87.5% and 47.2%, respectively, for T2-weighted FSE. 100.0% and 50.0% for DWI, 95.8% and 58.3% for DCE fat-suppressed T1-weighted SPGR, and 93.8% and 72.2% for T2-DWI with image fusion. Conclusion: For depicting locally recurrent pelvic malignancy, T2-DWI with image fusion outperforms standard T2-weighted FSE and DWI and is comparable to DCE fat-suppressed T1-weighted SPGR.

AB - Purpose: To evaluate the performance of T2- and diffusion-weighted magnetic resonance imaging (MRI) with image fusion for detection of locally recurrent pelvic malignancy. Materials and Methods: The study group consisted of 28 patients (27 female, 1 male) who underwent pelvic MRI at 1.5 T after treatment of pelvic malignancy. MR images were reviewed independently by three blinded readers. The performance of the four sequences for detecting local recurrence was evaluated using receiver operating characteristic analysis: T2-weighted fast spin-echo (FSE), diffusion-weighted echo-planar imaging (DWI), dynamic contrast-enhanced (DCE) fat-suppressed T1-weighted spoiled gradient echo (SPGR), and T2-DWI with image fusion, the latter created using OsiriX Medical Imaging Software. Results: Local recurrence was confirmed at biopsy in 16 patients. Twelve patients showed no evidence of recurrence on two consecutive MRI studies. The Az value for T2-DWI with image fusion (0.949) was statistically greater than that for T2-weighted FSE (0.849) (P < 0.05). The sensitivity and specificity was 87.5% and 47.2%, respectively, for T2-weighted FSE. 100.0% and 50.0% for DWI, 95.8% and 58.3% for DCE fat-suppressed T1-weighted SPGR, and 93.8% and 72.2% for T2-DWI with image fusion. Conclusion: For depicting locally recurrent pelvic malignancy, T2-DWI with image fusion outperforms standard T2-weighted FSE and DWI and is comparable to DCE fat-suppressed T1-weighted SPGR.

UR - http://www.scopus.com/inward/record.url?scp=51449091766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51449091766&partnerID=8YFLogxK

U2 - 10.1002/jmri.21486

DO - 10.1002/jmri.21486

M3 - Article

C2 - 18777555

AN - SCOPUS:51449091766

VL - 28

SP - 705

EP - 713

JO - Journal of Magnetic Resonance Imaging

JF - Journal of Magnetic Resonance Imaging

SN - 1053-1807

IS - 3

ER -